Actively Recruiting
The Prospecive OBSERVational Munich Interventional MITRAl-Valve Registry
Led by Deutsches Herzzentrum Muenchen · Updated on 2020-10-08
5000
Participants Needed
1
Research Sites
537 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Prospective, single-center observational registry including all consecutive patients treated with transcatheter mitral or tricuspid valve therapy at the Deutsches Herzzentrum München, Germany.
CONDITIONS
Official Title
The Prospecive OBSERVational Munich Interventional MITRAl-Valve Registry
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age above 18 years and able to give consent
- Diagnosis of mitral valve regurgitation, mitral valve stenosis, tricuspid valve regurgitation, or tricuspid stenosis
- Transcatheter mitral or tricuspid valve therapy considered the best option by a heart team
- Written informed consent provided
You will not qualify if you...
- Inability to fully cooperate with the study protocol
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Deutsches Herzzentrum München des Freistaates Bayern, Technische Universität München
Munich, Bavaria, Germany, D80636
Actively Recruiting
Research Team
P
Patrick Mayr, MD
CONTACT
J
Joner Michael, Prof
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here